Eric GUERIN

MCUPH

ORCID – ResearcherID

(+33) 03 88 12 75 37

 

 

 

Liste des publications :

 

Vidimar, V., Licona, C., Cerón-Camacho, R., Guerin, E., Coliat, P., Venkatasamy, A., … Gaiddon, C. (2019). A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53. Cancer Letters, 440441, 145–155. https://doi.org/10.1016/j.canlet.2018.09.029
Lhermitte, B., Blandin, A. F., Coca, A., Guerin, E., Durand, A., & Entz-Werlé, N. (2018). Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas. Neuro-Chirurgie. https://doi.org/10.1016/j.neuchi.2018.01.003
Prim, N., Legrain, M., Guerin, E., Mennecier, B., Weingertner, N., Voegeli, A.-C., … Beau-Faller, M. (2014). Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients. European Respiratory Review: An Official Journal of the European Respiratory Society, 23(133), 390–392. https://doi.org/10.1183/09059180.00009313
Nguyen, A., Lasthaus, C., Guerin, E., Marcellin, L., Pencreach, E., Gaub, M.-P., … Entz-Werle, N. (2013). Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse. Cancers, 5(2), 662–675. https://doi.org/10.3390/cancers5020662
Janouskova, H., Maglott, A., Leger, D. Y., Bossert, C., Noulet, F., Guerin, E., … Dontenwill, M. (2012). Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. Cancer Research, 72(14), 3463–3470. https://doi.org/10.1158/0008-5472.CAN-11-4199
Martin, E., Vanier, M., Tavian, M., Guerin, E., Domon-Dell, C., Duluc, I., … Freund, J.-N. (2010). CDX2 in congenital gut gastric-type heteroplasia and intestinal-type Meckel diverticula. Pediatrics, 126(3), e723-727. https://doi.org/10.1542/peds.2009-3512
Domon-Dell, C., Schneider, A., Moucadel, V., Guerin, E., Guenot, D., Aguillon, S., … Freund, J.-N. (2003). Cdx1 homeobox gene during human colon cancer progression. Oncogene, 22(39), 7913–7921. https://doi.org/10.1038/sj.onc.1206756